CN1136878C - Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis - Google Patents

Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis Download PDF

Info

Publication number
CN1136878C
CN1136878C CNB011040335A CN01104033A CN1136878C CN 1136878 C CN1136878 C CN 1136878C CN B011040335 A CNB011040335 A CN B011040335A CN 01104033 A CN01104033 A CN 01104033A CN 1136878 C CN1136878 C CN 1136878C
Authority
CN
China
Prior art keywords
parts
radix
semen
medicine
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB011040335A
Other languages
Chinese (zh)
Other versions
CN1310000A (en
Inventor
孟庆云
孟繁宇
孟繁勇
郭宏艳
陈淑琴
王建华
董树江
孟祥辉
Original Assignee
孟庆云
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4653632&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1136878(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 孟庆云 filed Critical 孟庆云
Priority to CNB011040335A priority Critical patent/CN1136878C/en
Publication of CN1310000A publication Critical patent/CN1310000A/en
Application granted granted Critical
Publication of CN1136878C publication Critical patent/CN1136878C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a medicament for treating cardiopulmonary diseases in catabasis, which comprises traditional Chinese medicine and western medicine. The medicament is characterized in that the traditional Chinese medicine is prepared from tokay gecko, epimedium, Chinese yam, ginseng, ophiopogon root, Chinese magnolivine fruit, stemona root, largehead atractylodes rhizome, sapanwood, cassia twig, poria from Yunnan of China, peach seed, coltsfoot, apricot kernel, heartleaf houttuynia herb, semen, fritillaria thunbergii, prepared liauorice root, raw milkvetch root, earthworm, red sage root, malaytea scurfpea fruit, prepared common monkshood daughter root, rhizoma drynariae and dry ant as raw materials by a conventional method for oral taking, and the traditional Chinese medicine is used cooperatively with the western medicine which comprises phlegm elimination acetonidum A for eliminating phlegm, nucleic junket and Bacillus-Calmette-Guerin vaccination for acupoint injection for jointly treating cardiopulmonary diseases. The present invention has the advantages and the effects of good curative effect, high cure rate, no side effect and low relapse rate.

Description

The medicine of one cover treatment catabasis pulmonary heart disease
The present invention relates to the medicine of a cover treatment catabasis pulmonary heart disease, specifically it is to be the Chinese medicine that raw material prepares according to a conventional method with the Chinese herbal medicine, cooperates the medicament of acupoint injection therapy Western medicine therapeutic alliance catabasis pulmonary heart disease again.
Pulmonary heart disease is a chronic bronchitis, bronchial asthma, or the final stage of other pulmonary disease development, mainly be because chronic bronchitis causes the heart disease that pulmonary hypertension caused of lung tissue or pulmonary artery and ramose primary affection thereof, much more comparatively to see in the rural area, sickness rate accounts for about 0.9% around in Beijing, only cause of death investigation statistics shows over 10 years, pulmonary heart disease tops the list in the cause of death of local rural area, at present, the treatment pulmonary heart disease does not have specific drug, most with antiinflammatory, cough-relieving, relieving asthma or with the treatment cardiopathic medicine treat, its effect is undesirable, relapse rate height, mortality rate height.
The objective of the invention is shortcoming and deficiency in order to overcome above-mentioned prior art, and provide a kind of is the Chinese medicine that raw material is made according to a conventional method with the Chinese herbal medicine, cooperate the Western medicine therapeutic alliance catabasis pulmonary heart disease of acupoint injection therapy again, thereby can effectively treat disease, improved cure rate greatly.
The objective of the invention is to realize by following technical proposal:
The medicine of one cover treatment catabasis pulmonary heart disease, it is made up of Chinese medicine and Western medicine, and it is to carry out decocting extraction medicinal liquid according to a conventional method by the following weight proportion raw material to make capsule through concentrate drying powder process to it is characterized in that described Chinese medicine:
Dried Gecko 20-40 part Herba Epimedii 10-20 part Rhizoma Dioscoreae 20-30 part Radix Ginseng 10-15 part
Radix Ophiopogonis 10-15 part Fructus Schisandrae Chinensis 15-20 part Radix Stemonae 15-20 part Rhizoma Atractylodis Macrocephalae 20-30 part
Lignum Sappan 10-15 part Ramulus Cinnamomi 10-15 part Poria 15-20 part Semen Persicae 10-15 part
Flos Farfarae 15-20 part Semen Armeniacae Amarum 10-15 part Herba Houttuyniae 30-40 part Semen Lepidii (Semen Descurainiae) 15-20 part
Bulbus Fritillariae Thunbergii 15-20 part Radix Glycyrrhizae Preparata 10-15 part Radix Astragali 15-20 part Pheretima 10-15 part
Radix Salviae Miltiorrhizae 20-30 part Fructus Psoraleae 15-20 part Radix Aconiti Lateralis Preparata 10-30 part Rhizoma Drynariae 10-20 part
Dried Formica fusca 10-20 part.
Described Western medicine is nuclear cheese and Si Qikang injection.
The excellent weight proportion of making of each raw material of Chinese medicine of the present invention is:
Dried Gecko 25-35 part Herba Epimedii 15-20 part Rhizoma Dioscoreae 20-25 part Radix Ginseng 12-15 part
Radix Ophiopogonis 10-12 part Fructus Schisandrae Chinensis 18-20 part Radix Stemonae 15-18 part Rhizoma Atractylodis Macrocephalae 20-25 part
Lignum Sappan 12-15 part Ramulus Cinnamomi 10-12 part Poria 18-20 part Semen Persicae 10-12 part
Flos Farfarae 15-18 part Semen Armeniacae Amarum 12-15 part Herba Houttuyniae 35-40 part Semen Lepidii (Semen Descurainiae) 18-20 part
Bulbus Fritillariae Thunbergii 15-18 part Radix Glycyrrhizae Preparata 12-15 part Radix Astragali 18-20 part Pheretima 12-15 part
Radix Salviae Miltiorrhizae 20-25 part Fructus Psoraleae 18-20 part Radix Aconiti Lateralis Preparata 15-25 part Rhizoma Drynariae 15-18 part
Dried Formica fusca 15-18 part.
The optimum weight proportioning of each raw material of Chinese medicine of the present invention is:
12 parts of 22 parts of Radix Ginsengs of 18 portions of Rhizoma Dioscoreaes of 30 parts of Herba Epimedii of dried Gecko
22 parts of 18 parts of Rhizoma Atractylodis Macrocephalaes of 18 parts of Radixs Stemonae of 12 parts of Fructus Schisandrae Chinensis Radix Ophiopogonis
10 parts in 20 parts of Semen Persicaes of 12 parts of Poria of 12 parts of Ramulus Cinnamomi of Lignum Sappan
18 parts of 35 parts of Semen Lepidii (Semen Descurainiae)s of 12 parts of Herba Houttuyniae of 15 parts of Semen Armeniacae Amarums of Flos Farfarae
12 parts of 18 parts of Pheretimas of 12 parts of Radix Astragali of 15 parts of Radix Glycyrrhizae Preparatas of Bulbus Fritillariae Thunbergii
15 parts of 20 parts of Rhizoma Drynariae of 18 parts of Radix Aconiti Lateralis Preparatas of 20 parts of Fructus Psoraleae of Radix Salviae Miltiorrhizae
15 parts of dried Formica fuscas.
Owing to during the pulmonary heart disease acute attack that bronchial asthma causes, increase the Triamcinolone Acetonide acupoint injection therapy again.
Patients with cor pulmonale, owing to show effect and long-term severe depletion of oxygen repeatedly, repeated infection, lung tissue is blood stasis in various degree, and of a specified duration can cause adrenal cortex secretion wretched insufficiency, the normal person secretes hydrocortisone 25mg every day, secrete 250mg in case of necessity, when functional disorder, acth secretion seriously reduces, general weakness can appear, the waist lower limb is soft, the resisting cold ability is very low, mucocutaneous pigment is felt.The whole body cyanosis, modern medicine study thinks that pulmonary heart disease has the serious low evidence of hypophysis-adrenal cortex function, respectively organize severe depletion of oxygen, confirm that through literature survey research and pharmacological research kidney-reinforcing drug can improve this function, illustrates that the kidney invigorating therapy meets modern medical theory, through for many years clinical practice proof its by increasing effect of adrenal cortex function, promote the body cell metabolism, improve the low situation of body's immunity, improve the nonspecific defense function of body, can resist the change and the extraneous infective agent of weather, pathological change is developed towards the direction that helps the body reparation, and by the expansible blood vessel of removing blood stasis blood medicine, logical blood flow relaxes, microcirculation improvement, increase lung tissue hemoperfusion amount, improve pathological change, pass through acupoint injection therapy again, stimulating acupoint is brought about the desired sensation, dredging the meridian, QI and blood, negative and positive are regulated internal organs, therapy of combining Chinese and Western medicine, specimen is held concurrently solid, the performance cooperative effect is improved the heart, lung, renal function promotes early recovery.
Chinese medicine preparation of the present invention is according to theory of Chinese medical science, in conjunction with for many years clinical practice and the result who sums up.
Wherein: Radix Ginseng, Radix Ophiopogonis, Fructus Schisandrae Chinensis, the Rhizoma Atractylodis Macrocephalae, Lignum Sappan, Ramulus Cinnamomi, Radix Astragali, Radix Salviae Miltiorrhizae, Radix Aconiti Lateralis Preparata are monarch drug; Dried Gecko, Herba Epimedii, Rhizoma Dioscoreae are ministerial drug; Semen Armeniacae Amarum, Herba Houttuyniae, Semen Lepidii (Semen Descurainiae) are adjuvant drug; All the other are messenger drug.
Chinese medicine of the present invention has the kidney invigorating lung benefiting, hold concurrently solid heart spleen, cough-relieving, really expectorant, antiinflammatory, the adjusting equilibrium between yin and yang of relievining asthma, compensate qi and blood, and removing blood stasis is invigorated blood circulation, blood vessel dilating, the logical blood flow that relaxes, microcirculation improvement, increase lung tissue hemoperfusion amount, increase immunologic function, make it to cure.
Acupoint injection therapy, conventional acupoint selection are Dingchuan, Danzhong, feishu, canopy, Xinshu, Shenshu, the concurrent infection abundant expectoration: Tiantu, foot three reasons.
The pulmonary heart disease Western medicine injection acupuncture point that bronchial asthma causes: Shenshu, Xinshu.
The acupuncture point effect:
DINGCHUAN acupoint: can relieving asthma and cough, lung qi dispersing is regulated the flow of vital energy; Point cv 20: the energy resolving phlegm and relieving asthma, the sending down the abnormal ascending QI cough-relieving, the internal organs of having a strong smell are the positions of internal organs through the gas infusion, TIANTU acupoint is that acupoints on Ren channel potential energy lung qi dispersing is had one's ideas straightened out sore-throat relieving eliminating stagnation, eliminating phlegm and lowering adverse QI.Equilibrium between yin and yang is regulated in the tsu san li the kidney invigorating, and all caves cooperate injection to play the effect of lowering the adverse-rising QI to subdue asthma expectorant altogether.
The Western medicine Triamcinolone Acetonide is a hormone medicine, is used for acute attack, has antiinflammatory, anti-allergic effects, effectively controlling symptoms.Si Qikang and nuclear cheese can improve the immunity of body, prevent flu.
By the acupoint injection therapy Western medicine, the meridian dredging that can relax increases curative effect of medication, regulates zang-fu disharmony, and Yin Yang balancing increases immunologic function, plays the effect of acupuncture.Function is regulated in the Chinese and Western combination, and the human body immunity improving function increases resistance against diseases, improves lung, spleen, renal function, reaches the purpose of healthy recovery from illness.
Clinical test results:
One, clinical data:
1000 examples are organized in treatment, male 600 examples, and women 400 examples, the age, the course of disease is the longest 60 years, and was the shortest 5 years in 30-70 year, merged coronary heart disease 320 examples, emphysema 50 examples.
Two, diagnosis basis:
1, there are chronic bronchitis, bronchial asthma, emphysema and other to cause the structure of lung or functional lesion and cause the disease of hypertrophy of right heart.
2, symptom and sign: chronic cough, excessive phlegm symptom and emphysema sign are arranged, there are enhanced systole pollex and/or TA hear sounds obviously to strengthen under the xiphoid-process or systolic murmur occurs, second sound of pulmonary area is obviously hyperfunction, cardiopalmus occurs in acute respiratory infection or after, breathe hard and symptom such as cyanosis and right merit aroused in interest are not all levied than aggravating activities.
3, chest x-ray diagnosis:
(1) arteriosus truncus expansion: transverse diameter 〉=1.5cm under the right lung, the broadening of arteriosus truncus transverse diameter reaches more than the 2mm under the right lung through dynamic observing;
(2), pulmonary artery protrudes, highly 〉=3mm;
(3), center pulmonary artery expansion and periphery branch very thin both form sharp contrast, be " undesirable root shape ";
(4), diaphram descends adhesion;
(5) the narrow shape heart;
(6) right ventricle increases;
Have (1)-(5) in more than two or (6) item person diagnosable.
4, Electrocardioscopy:
(1) axle right avertence;
(2) repeat clockwise rotation;
(3) P of pulmonary ripple.
Three, Therapeutic Method:
Patient's oral Chinese medicine, day clothes 3 times, serve on 6 months by each 8.
Acupoint injection therapy: Si Qikang and nuclear cheese, consumption 2ml, injection in per three days once exchanged Western medicine and injects in per three days.
Acupuncture point: feishu, Dingchuan, canopy, Xinshu, Shenshu, Danzhong, Tiantu, tsu san li.
Cooperate cytochrome C, each 30mg and 25% glucose intravenous injection, glycosuria patient use normal saline, twice of every day.
Because during the pulmonary heart disease acute attack that bronchial asthma causes, increase Shenshu, the Xinshu acupoint injection therapy scorching relaxed and comfortable A that dispels, per three days are once, each 2ml.
Four, treatment time: the catabasis after the acute attack control.
Five, treatment standard:
Chronic pulmonary heart disease illness analysis and curative effect judging standard according to whole nation pulmonary heart disease specialized conference formulation for the second time in 1977.
Six, therapeutic outcome:
Each age group patients with cor pulmonale therapeutic outcome
Age 30-40 year 41-60 year is more than 61 years old
Total example several 30 50 270 130 300 220
Sex men and women men and women men and women
Cure 82 34 12 56 25
Take a turn for the better 20 42 208 106 204 160
Invalid 26 28 12 40 35
Cure rate 12.5% 11.5% 15.57%
Improvement rate 77.5% 78.5% 70%
Inefficiency 10% 10% 14.43%
Model case:
Yan, the man, 76 years old, the Cantonese suffered from bronchial asthma 36 years, breathed hard, and dyspnea 20 years increased the weight of 16 years, once at regional hospital admissions such as Guangzhou, Beijing, was diagnosed as bronchial asthma, emphysema, pulmonary heart disease, unsatisfactory curative effect.Transfer me and institute go to a doctor, through the treatment of three courses of treatment, symptom all disappears, the rabat prompting, and heart is normal substantially, and the lung inflation amount disappears; Electrocardiogram is normal; Vital capacity is increased to 2850ml by 1000ml.So far 5 years are not complicated, and engage in trade in the city.
The king so-and-so, the man, 60 years old, the Pekinese suffered from bronchial asthma 30 years, increase the weight of year by year, uncomfortable in chest during outbreak, breathe hard, breathe and be the devil, moving then breathe heavily, once merge coronary heart disease treatment with asthma, emphysema, pulmonary heart disease in how tame hospitals such as Beijing Hospital, Army Hospitals, effect is all not obvious, introduces me institute to go to a doctor through friend.Through two course of therapy, symptom all disappears, and two diaphragm range of activity are normal, and hypertrophy of right heart disappears, and electrocardiogram is normal, and vital capacity is increased to 2700ml by 500ml, so far not recurrence.
Tang so-and-so, the man, 70 years old, people from Tong County, the chronic discontinuity cough with asthma of patient was panted 46 years, with cardiopalmus, breathe hard, dyspnea, moving then increase the weight of, once to Beijing, Tong County hospital seeks medical advice in many ways and do not feel any better.Come electrograph normal, vital capacity is increased to 2700ml by 500ml, so far not recurrence.
Tang so-and-so, the man, 70 years old, people from Tong County, the chronic discontinuity cough with asthma of patient was panted 46 years, with cardiopalmus, breathe hard, dyspnea, moving then increase the weight of, once to Beijing, Tong County hospital seeks medical advice in many ways and do not feel any better.Come me institute to go to a doctor, through three course of therapy, symptom all disappears, edema of pair of lower extremities disappears, heart circle is carried on lung voiced sound circle near normal, rabat prompting: carry on the diaphram, lung marking is slightly thick, podiod is roughly normal, and electrocardiogram, electric axis are not inclined to one side, no transposition, and vital capacity is increased to 2700ml by 1500ml, can participate in normal work, so far not recurrence.
Owing to adopt technique scheme, make the technology of the present invention compared with the prior art have following advantage and effect:
A) adopt the integrative therapy pulmonary heart disease to recover adrenocortical function by Chinese medicine, the human body immunity improving ability reaches the specimen hair strengthening of holding concurrently by acupoint injection therapy again and waves cooperative effect, promotes early recovery;
B), prescription is scientific and reasonable, preparation method is simple;
C), therapeutic effect is good, cure rate height, no side effects.
Embodiment 1:
Get dried Gecko 30g, Herba Epimedii 18g, Rhizoma Dioscoreae 22g, Radix Ginseng 12g, Radix Ophiopogonis 12g, Fructus Schisandrae Chinensis 18g, Radix Stemonae 18g, Rhizoma Atractylodis Macrocephalae 22g, Lignum Sappan 12g, Ramulus Cinnamomi 12g, Poria 20g, Semen Persicae 10g, Flos Farfarae 15g, Semen Armeniacae Amarum 12g, Herba Houttuyniae 35g, Semen Lepidii (Semen Descurainiae) 18g, Bulbus Fritillariae Thunbergii 15g, Radix Glycyrrhizae Preparata 12g, Radix Astragali 18g, Pheretima 12g, Radix Salviae Miltiorrhizae 20g, Fructus Psoraleae 18g, Radix Aconiti Lateralis Preparata 20g, Rhizoma Drynariae 15g, carry out decocting after 15 parts of mixing of dried Formica fusca according to a conventional method and extract medicinal liquid,, make capsule through concentrate drying powder process, every 0.5g is product through being up to the standards.
Cooperate Western medicine acupoint injection therapy nuclear cheese and Si Qikang during treatment, the pulmonary heart disease injection Triamcinolone Acetonide that bronchial asthma causes.
Embodiment 2:
Get dried Gecko 20g, Herba Epimedii 20g, Rhizoma Dioscoreae 20g, Radix Ginseng 15g, Radix Ophiopogonis 10g, Fructus Schisandrae Chinensis 20g, Radix Stemonae 15g, Rhizoma Atractylodis Macrocephalae 30g, Lignum Sappan 10g, Ramulus Cinnamomi 15g, Poria 15g, Semen Persicae 12g, Flos Farfarae 18g, Semen Armeniacae Amarum 10g, Herba Houttuyniae 40g, Semen Lepidii (Semen Descurainiae) 15g, Bulbus Fritillariae Thunbergii 20g, Radix Glycyrrhizae Preparata 10g, Radix Astragali 15g, Pheretima 10g, Radix Salviae Miltiorrhizae 30g, Fructus Psoraleae 15g, Radix Aconiti Lateralis Preparata 30g, Rhizoma Drynariae 10g, carry out decocting after 10 parts of mixing of dried Formica fusca according to a conventional method and extract medicinal liquid,, make capsule through concentrate drying powder process, every 0.5g is product through being up to the standards.
Cooperate Western medicine acupoint injection therapy nuclear cheese and Si Qikang during treatment, the pulmonary heart disease injection Triamcinolone Acetonide that bronchial asthma causes.
Embodiment 3:
Get dried Gecko 40g, Herba Epimedii 10g, Rhizoma Dioscoreae 30g, Radix Ginseng 10g, Radix Ophiopogonis 15g, Fructus Schisandrae Chinensis 15g, Radix Stemonae 20g, Rhizoma Atractylodis Macrocephalae 20g, Lignum Sappan 15g, Ramulus Cinnamomi 10g, Poria 18g, Semen Persicae 15g, Flos Farfarae 20g, Semen Armeniacae Amarum 15g, Herba Houttuyniae 30g, Semen Lepidii (Semen Descurainiae) 20g, Bulbus Fritillariae Thunbergii 18g, Radix Glycyrrhizae Preparata 15g, Radix Astragali 20g, Pheretima 15g, Radix Salviae Miltiorrhizae 25g, Fructus Psoraleae 20g, Radix Aconiti Lateralis Preparata 10g, Rhizoma Drynariae 20g, carry out decocting after 20 parts of mixing of dried Formica fusca according to a conventional method and extract medicinal liquid,, make capsule through concentrate drying powder process, every 0.5g is product through being up to the standards.
Cooperate Western medicine acupoint injection therapy nuclear cheese and Si Qikang during treatment, the pulmonary heart disease injection Triamcinolone Acetonide that bronchial asthma causes.

Claims (4)

1, the medicine of a cover treatment catabasis pulmonary heart disease, it is made up of Chinese medicine and Western medicine, and it is to carry out decocting according to a conventional method by the following weight proportion raw material to extract the capsule that medicinal liquid is made through concentrate drying powder process to it is characterized in that described Chinese medicine:
Dried Gecko 20-40 part Herba Epimedii 10-20 part Rhizoma Dioscoreae 20-30 part Radix Ginseng 10-15 part
Radix Ophiopogonis 10-15 part Fructus Schisandrae Chinensis 15-20 part Radix Stemonae 15-20 part Rhizoma Atractylodis Macrocephalae 20-30 part
Lignum Sappan 10-15 part Ramulus Cinnamomi 10-15 part Poria 15-20 part Semen Persicae 10-15 part
Flos Farfarae 15-20 part Semen Armeniacae Amarum 10-15 part Herba Houttuyniae 30-40 part Semen Lepidii (Semen Descurainiae) 15-20 part
Bulbus Fritillariae Thunbergii 15-20 part Radix Glycyrrhizae Preparata 10-15 part Radix Astragali 15-20 part Pheretima 10-15 part
Radix Salviae Miltiorrhizae 20-30 part Fructus Psoraleae 15-20 part Radix Aconiti Lateralis Preparata 10-30 part Rhizoma Drynariae 10-20 part
Dried Formica fusca 10-20 part.
Described Western medicine is nuclear cheese and Si Qikang injection.
2, the medicine of a cover treatment pulmonary heart disease according to claim 1 is characterized in that the weight proportion of described each raw material of Chinese medicine is:
Dried Gecko 25-35 part Herba Epimedii 15-20 part Rhizoma Dioscoreae 20-25 part Radix Ginseng 12-15 part
Radix Ophiopogonis 10-12 part Fructus Schisandrae Chinensis 18-20 part Radix Stemonae 15-18 part Rhizoma Atractylodis Macrocephalae 20-25 part
Lignum Sappan 12-15 part Ramulus Cinnamomi 10-12 part Poria 18-20 part Semen Persicae 10-12 part
Flos Farfarae 15-18 part Semen Armeniacae Amarum 12-15 part Herba Houttuyniae 35-40 part Semen Lepidii (Semen Descurainiae) 18-20 part
Bulbus Fritillariae Thunbergii 15-18 part Radix Glycyrrhizae Preparata 12-15 part Radix Astragali 18-20 part Pheretima 12-15 part
Radix Salviae Miltiorrhizae 20-25 part Fructus Psoraleae 18-20 part Radix Aconiti Lateralis Preparata 15-25 part Rhizoma Drynariae 15-18 part
Dried Formica fusca 15-18 part.
3, the medicine of a cover treatment pulmonary heart disease according to claim 1 is characterized in that the weight proportion of described each raw material of Chinese medicine is:
12 parts of 22 parts of Radix Ginsengs of 18 portions of Rhizoma Dioscoreaes of 30 parts of Herba Epimedii of dried Gecko
22 parts of 18 parts of Rhizoma Atractylodis Macrocephalaes of 18 parts of Radixs Stemonae of 12 parts of Fructus Schisandrae Chinensis Radix Ophiopogonis
10 parts in 20 parts of Semen Persicaes of 12 parts of Poria of 12 parts of Ramulus Cinnamomi of Lignum Sappan
18 parts of 35 parts of Semen Lepidii (Semen Descurainiae)s of 12 parts of Herba Houttuyniae of 15 parts of Semen Armeniacae Amarums of Flos Farfarae
12 parts of 18 parts of Pheretimas of 12 parts of Radix Astragali of 15 parts of Radix Glycyrrhizae Preparatas of Bulbus Fritillariae Thunbergii
15 parts of 20 parts of Rhizoma Drynariae of 18 parts of Radix Aconiti Lateralis Preparatas of 20 parts of Fructus Psoraleae of Radix Salviae Miltiorrhizae
15 parts of dried Formica fuscas.
4, the medicine of a cover treatment pulmonary heart disease according to claim 1 is characterized in that described Western medicine also has the Triamcinolone Acetonide injection.
CNB011040335A 2001-02-19 2001-02-19 Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis Expired - Fee Related CN1136878C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB011040335A CN1136878C (en) 2001-02-19 2001-02-19 Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011040335A CN1136878C (en) 2001-02-19 2001-02-19 Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis

Publications (2)

Publication Number Publication Date
CN1310000A CN1310000A (en) 2001-08-29
CN1136878C true CN1136878C (en) 2004-02-04

Family

ID=4653632

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011040335A Expired - Fee Related CN1136878C (en) 2001-02-19 2001-02-19 Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis

Country Status (1)

Country Link
CN (1) CN1136878C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102441129B (en) * 2011-12-02 2013-07-17 香河县气管炎哮喘医院 Traditional Chinese medicine for treating chronic pulmonary heart disease
CN103169905B (en) * 2012-03-31 2014-04-30 陈欣 Traditional Chinese medicine capsule preparation for treating lung-heart disease and preparation method thereof
CN103169907B (en) * 2012-03-31 2014-06-18 毕玉珍 Traditional Chinese medicine tablet preparation for treating lung-heart disease and preparation method thereof
CN103169906B (en) * 2012-03-31 2014-06-18 李风芹 Traditional Chinese medicine powder preparation for treating lung-heart disease and preparation method thereof
CN105147744A (en) * 2015-10-29 2015-12-16 北京岐黄制药有限公司 Drynaria rhizome and application of extract of drynaria rhizome for preventing or treating pulmonary heart disease

Also Published As

Publication number Publication date
CN1310000A (en) 2001-08-29

Similar Documents

Publication Publication Date Title
CN1970069B (en) Chinese medicinal pill for treating coronary heart disease
CN102526674A (en) Medicine for treating bronchitis and bronchial asthma suffered by children aging from three to seven
CN102552773A (en) Drug for treating bronchitis and bronchial asthma of 7-15 year old children
CN1840006A (en) Medicine for treating aplastic anemia
CN1167454C (en) Chinese medicine for detoxication purpose and its preparing process
CN100493586C (en) Oral liquid for treating breast cancer, liver cancer or lung caner, and preparation thereof
CN1136878C (en) Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis
CN102283956A (en) Orally administered drug for treating chronic hepatitis
CN1136880C (en) Combined Chinese and Western medicine for treating bronchial asthma
CN1915345A (en) External preparation of Chinese traditional medicine for improving ascites due to cirrhosis, and preparation method
CN1136881C (en) Combined Chinese and Western medicine for treating pulmonary emphysema
CN1136879C (en) Combined Chinese and Western medicine for treating chronic bronchitis in catabasis
CN108404105A (en) A kind of dispelling cold and dehumidification alleviates the Chinese medicine preparation of head-body-pain
CN101234167B (en) Chinese medicine for treating bronchial asthma and chronic bronchitis
CN103536849A (en) Drug for treating pulmonary embolism and preparation method thereof
CN104042887B (en) Compound medicine for treating pulmonary heart disease and preparation method and application thereof
CN105456887A (en) Pharmaceutical for treating aplastic anemia
CN105106508A (en) Cocklebur fruit allergic rhinitis paste
CN1245197C (en) Chinese medicine preparation for treating coronary heart disease and viral myocarditis
CN1201811C (en) Chinese medicine composition for treating myopia and preparing method thereof
CN1051018C (en) Stomach-kidney health-care bag
CN105853635A (en) Pharmaceutical composition for treating angina pectoris of coronary heart disease
CN105311222A (en) Traditional Chinese medicine composition for treating chronic heart failure
CN105327045A (en) Lipid-lowering traditional Chinese medicine for treating NAFLD (non-alcoholic fatty liver diseases) and treatment method
CN104027571A (en) Traditional Chinese medicine composition for treating chronic pulmonary heart disease

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040204

Termination date: 20190219

CF01 Termination of patent right due to non-payment of annual fee